Related Experiment Videos
Preferences for new and existing contraceptive products
Denzil G Fiebig1, Stephanie Knox, Rosalie Viney
1School of Economics, University of New South Wales, Sydney, Australia. d.fiebig@unsw.edu.au
Health Economics
|August 3, 2011
Summary
Women prefer new contraceptive options like the hormonal patch over the vaginal ring. Understanding these preferences is key for predicting uptake and informing healthcare providers about patient choices in contraception.
Area of Science:
- Reproductive Health
- Health Services Research
- Behavioral Economics
Background:
- New contraceptive methods offer diverse choices but complicate decision-making.
- Limited data exists on factors influencing women's contraceptive choices.
- Predicting uptake of novel contraceptive products is challenging.
Purpose of the Study:
- To investigate women's preferences for prescribed contraception.
- To forecast the market impact of new contraceptive products in Australia.
- To inform healthcare providers on key factors important to women.
Main Methods:
- A choice experiment was conducted to elicit women's preferences.
- A generalised multinomial logit model was estimated.
- Simulation exercises were performed to forecast market share.
Main Results:
- The hormonal patch is predicted to be well-received by women.
- The hormonal patch is forecasted to capture a significant market share.
- The vaginal ring is predicted to have limited appeal among users.
Conclusions:
- Women's preferences can be modeled to predict uptake of new contraceptives.
- The hormonal patch shows strong potential for market success.
- Understanding user preferences is crucial for introducing new contraceptive technologies.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...